Antimicrobial peptides in human corneal tissue of patients with fungal keratitis

Imran Mohammed1, Debasmita Mohanty2, Dalia G Said1,3

  • 1Academic Ophthalmology, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham United Kingdom.

Abstract

Insights

Antimicrobial peptides (AMPs), including human beta-defensins (HBDs), are upregulated in fungal keratitis (FK). HBD-1 and HBD-2 show the most consistent expression, offering potential for FK-specific peptide therapeutics.

Area of Science:

  • Ophthalmology
  • Immunology
  • Microbiology

Background:

  • Fungal keratitis (FK) is a leading cause of unilateral blindness in developing nations.
  • Antimicrobial peptides (AMPs) are crucial for ocular surface defense against various pathogens.
  • This study investigates AMP profiles in corneal tissue during active FK and after healing.

Purpose of the Study:

  • To profile the expression of specific AMPs in corneal tissue from FK patients.
  • To compare AMP expression during active infection versus healed stages.
  • To identify potential therapeutic targets for FK.

Main Methods:

  • Ocular surface samples collected via cytology and scraping.
  • Corneal buttons from therapeutic keratoplasty used for severe/healed FK.
  • Quantitative real-time PCR used to measure gene expression of HBD-1, -2, -3, -9, S100A7, and LL-37.

Main Results:

  • All investigated AMPs showed significant messenger RNA (mRNA) upregulation in active FK samples.
  • HBD-1 and HBD-2 mRNA were elevated in 18/20 FK samples.
  • LL-37 mRNA showed moderate upregulation in 7/20 samples, with lower expression in healed tissues.

Conclusions:

  • AMP expression is a consistent characteristic of active fungal keratitis.
  • HBD-1 and HBD-2 exhibit the most consistent upregulation, suggesting specificity.
  • Findings may guide the development of FK-specific peptide-based therapies.